Literature DB >> 7439990

Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas.

G S Giebink, I K Berzins, S C Marker, G Schiffman.   

Abstract

Otitis media developed in 67% of chinchillas inoculated intranasally with type 7 Streptococcus pneumoniae and influenza A virus. Only 4% of chinchillas inoculated with influenza alone and 21% of chinchillas inoculated with S. pneumoniae alone developed otitis media. Among the chinchillas that developed otitis media after inoculation with both pneumococcus and influenza, 73% of the affected ears contained effusion, and 27% of the affected ears showed tympanic membrane inflammation without middle ear effusion obtained on paracentesis. Although a majority of the ears with effusion yielded S. pneumoniae on culture, one-third of the effusions were sterile for aerobic bacteria. This model resembles conditions accompanying otitis media in humans and suggests that respiratory viral infection contributes significantly to the pathogenesis of acute otitis media.

Entities:  

Mesh:

Year:  1980        PMID: 7439990      PMCID: PMC551333          DOI: 10.1128/iai.30.2.445-450.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Combined infections in mice with influenza virus and Diplococcus pneumoniae.

Authors:  P J GERONE; T G WARD; W A CHAPPELL
Journal:  Am J Hyg       Date:  1957-11

2.  Potentiation of experimental meningitis due to Haemophilus influenzae by influenza A virus.

Authors:  R H Michaels; R L Myerowitz; R Klaw
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

Review 3.  Otitis media: the spectrum of middle ear inflammation.

Authors:  G S Giebink; P G Quie
Journal:  Annu Rev Med       Date:  1978       Impact factor: 13.739

4.  Isolation of viruses and mycoplasmas from middle ear effusions: a review.

Authors:  J O Klein; D W Teele
Journal:  Ann Otol Rhinol Laryngol       Date:  1976 Mar-Apr       Impact factor: 1.547

5.  Modification of otitis media following vaccination with the capsular polysaccharide of Streptococcus pneumoniae in chinchillas.

Authors:  G S Giebink; G Schiffman; K Petty; P G Quie
Journal:  J Infect Dis       Date:  1978-10       Impact factor: 5.226

6.  Patterns of bacterial clearance in murine influenza.

Authors:  G M Green
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

7.  The role of respiratory syncytial virus in otitis media in children.

Authors:  B Berglund; A Salmivalli; J A Grönroos
Journal:  Acta Otolaryngol       Date:  1967-05       Impact factor: 1.494

8.  Cilia and mucus transport as determinants of the response of lung to air pollutants.

Authors:  K H Kilburn
Journal:  Arch Environ Health       Date:  1967-01

9.  Pulmonary and systemic defenses against challenge with Staphylococcus aureus in mice with pneumonia due to influenza A virus.

Authors:  G J Jakab; G A Warr; M E Knight
Journal:  J Infect Dis       Date:  1979-07       Impact factor: 5.226

10.  Synergistic effect in viral-bacterial infection. 2. Influence of viral infection on the phagocytic ability of alveolar macrophages.

Authors:  M Degré
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970
View more
  43 in total

Review 1.  Current research on respiratory viral infections: Third International Symposium.

Authors:  A C Schmidt; R B Couch; G J Galasso; F G Hayden; J Mills; B R Murphy; R M Chanock
Journal:  Antiviral Res       Date:  2001-06       Impact factor: 5.970

2.  Influenza virus induces bacterial and nonbacterial otitis media.

Authors:  Kirsty R Short; Dimitri A Diavatopoulos; Ruth Thornton; John Pedersen; Richard A Strugnell; Andrew K Wise; Patrick C Reading; Odilia L Wijburg
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

3.  A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media.

Authors:  Glen McGillivary; William C Ray; Charles L Bevins; Robert S Munson; Lauren O Bakaletz
Journal:  Mol Immunol       Date:  2006-11-20       Impact factor: 4.407

4.  Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization.

Authors:  Laura A Novotny; John D Clements; Lauren O Bakaletz
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

Review 5.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

6.  Complement activation in pediatric patients with recurrent acute otitis media.

Authors:  Yujuan He; Melissa A Scholes; Gregory J Wiet; Qian Li; Caitlin Clancy; Hua Hua Tong
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2013-03-26       Impact factor: 1.675

7.  Seasonality of acute otitis media and the role of respiratory viral activity in children.

Authors:  Chris Stockmann; Krow Ampofo; Adam L Hersh; Scott T Carleton; Kent Korgenski; Xiaoming Sheng; Andrew T Pavia; Carrie L Byington
Journal:  Pediatr Infect Dis J       Date:  2013-04       Impact factor: 2.129

Review 8.  Acute otitis media in children: association with day care centers--antibacterial resistance, treatment, and prevention.

Authors:  David Greenberg; Sigalit Hoffman; Eugene Leibovitz; Ron Dagan
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

9.  Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccine.

Authors:  Alison S Laufer; Jonathan C Thomas; Marisol Figueira; Janneane F Gent; Stephen I Pelton; Melinda M Pettigrew
Journal:  Vaccine       Date:  2010-01-10       Impact factor: 3.641

Review 10.  Immunopathogenesis of polymicrobial otitis media.

Authors:  Lauren O Bakaletz
Journal:  J Leukoc Biol       Date:  2009-10-20       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.